{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:40:10Z","timestamp":1794487210729,"version":"4.9.1"},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,4,5]],"date-time":"2005-04-05T00:00:00Z","timestamp":1112659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> BRAF is a member of the RAF kinase family, and it promotes signaling through the RAS\u2010MAP kinase signal transduction cascade. Research has shown that a majority of melanomas and nevi exhibit an activating V600E (T1799A) mutation in BRAF exon 15. Additional studies of BRAF have demonstrated that the T1799A mutation is absent in uveal melanomas and Spitz nevi.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> The ligase detection reaction (LDR) is a sensitive technique that can identify specific DNA mutations occurring at very low frequency within heterogeneous clinical samples, and it has previously been used to analyze mutations in paraffin\u2010embedded tissue specimens.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The LDR can readily detect mutations in DNA extracted from non\u2010microdissected paraffin\u2010embedded sections of common nevi, dysplastic nevi, and melanomas. In addition, this method demonstrated the absence of the V600E (T1799A) mutation within Spitz nevi.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> The LDR is a highly sensitive and specific test for detecting mutations in formalin\u2010fixed tissue. The LDR can be easily adapted to detect any mutation associated with a cutaneous disorder. The absence of the BRAF V600E mutation in <jats:bold>Spitz's nevi<\/jats:bold> may serve as a molecular signature to distinguish these lesions from common nevi, dysplastic nevi, and some types of malignant melanoma.<\/jats:p>","DOI":"10.1111\/j.0303-6987.2005.00338.x","type":"journal-article","created":{"date-parts":[[2005,4,5]],"date-time":"2005-04-05T11:31:49Z","timestamp":1112700709000},"page":"334-339","source":"Crossref","is-referenced-by-count":35,"title":["Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction"],"prefix":"10.1111","volume":"32","author":[{"given":"Daniel J.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monib A.","family":"Zirvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Barany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Elenitsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Seykora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,4,5]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766"},{"issue":"4","key":"e_1_2_5_3_2","first-page":"756","article-title":"Constitutive mitogen\u2010activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation","volume":"63","author":"Satyamoorthy K","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308709200"},{"issue":"23","key":"e_1_2_5_5_2","first-page":"6997","article-title":"BRAF and RAS mutations in human lung cancer and melanoma","volume":"62","author":"Brose MS","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00089-2"},{"issue":"14","key":"e_1_2_5_8_2","first-page":"3883","article-title":"BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma","volume":"63","author":"Dong J","year":"2003","journal-title":"Cancer Res"},{"issue":"14","key":"e_1_2_5_9_2","first-page":"3955","article-title":"Analysis of BRAF and N\u2010RAS mutations in metastatic melanoma tissues","volume":"63","author":"Gorden A","year":"2003","journal-title":"Cancer Res"},{"issue":"12","key":"e_1_2_5_10_2","first-page":"3061","article-title":"BRAF as a melanoma susceptibility candidate gene?","volume":"63","author":"Laud K","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1054"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200310000-00001"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12559.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202X.2004.22225.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202X.2004.22243.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-1329"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600919"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10188"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2003.00179.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(95)00041-X"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202291"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/27.24.e40"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/418934a"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00787.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64609-3"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59410-6_13"},{"issue":"17","key":"e_1_2_5_27_2","first-page":"6483","article-title":"NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression","volume":"9","author":"Omholt K","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(99)00020-X"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22722.x"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0303-6987.2005.00338.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0303-6987.2005.00338.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T07:54:20Z","timestamp":1697010860000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0303-6987.2005.00338.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1111\/j.0303-6987.2005.00338.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0303-6987.2005.00338.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,5]]}}}